The Journal of Immunology, Vol 143, Issue 12 4098-4103, Copyright © 1989 by American Association of Immunologists

ARTICLES

Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2

PA Robbins, LA Lettice, P Rota, J Santos-Aguado, J Rothbard, AJ McMichael and JL Strominger
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, England.

An influenza B virus nucleoprotein (BNP) peptide, residues 82-94, defined by limited sequence homology with an HLA-A2-restricted peptide from influenza A matrix protein, was recognized by HLA-A2-restricted CTL. Reciprocal inhibition of T cell recognition by the two peptides suggest that the BNP peptide may have lower avidity for HLA-A2 molecules than the matrix peptide. The interaction between this peptide and HLA-A2 was explored by studying the CTL recognition of BNP 82-94 presented by mutant HLA-A2 molecules. Mutations at residues 9, 99, 70, 74, 152 and 156 were found to abolish T cell recognition of the BNP peptide. These results were compared with results previously obtained with the influenza A matrix peptide and suggest that the two peptides bind differently in the peptide binding site.

This article has been cited by other articles:

				A. C. M. Boon, G. de Mutsert, R. A. M. Fouchier, K. Sintnicolaas, A. D. M. E. Osterhaus, and G. F. Rimmelzwaan Preferential HLA Usage in the Influenza Virus-Specific CTL Response J. Immunol., April 1, 2004; 172(7): 4435 - 4443. [Abstract] [Full Text] [PDF]

				F Latron, L Pazmany, J Morrison, R Moots, M. Saper, A McMichael, and J. Strominger A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells Science, August 14, 1992; 257(5072): 964 - 967. [Abstract] [PDF]